Supplementary Table 7 shows the top combination-cancer type pairs in hematological cancers showing activity in at least 10% of tested cell lines in that specific cancer type ranked based on their activity (% responders) and disease selectivity
No takes yet. Share an insight, caveat, or question.
Bashi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: